(Q60529806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Pieter J Westenend

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Joost Bart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Iris Nagtegaal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Joost Oudejans

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Henk-Jan van Slooten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Pieter Wesseling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Jelle Wesseling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Paul van der Valk

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Elsken van der Wall

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Laurien D C Hoefnagel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

S L Meijer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Cornelis A Seldenrijk

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Carla H van Gils

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Paul J van Diest

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

13 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

4929-4935

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

Variation in receptor status between primary and metastatic breast cancer.

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Progesterone receptor status of breast cancer metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Impact of metastatic estrogen receptor and progesterone receptor status on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

HER2 gene status in primary breast cancers and matched distant metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

HER2 protein and gene variation between primary and metastatic breast cancer: significance and impact on patient care.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

HER-2/neu expression in primary and metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Receptor conversion in distant breast cancer metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Should liver metastases of breast cancer be biopsied to improve treatment choice?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

One-time general consent for research on biological samples: opt out system for patients is optimal and endorsed in many countries

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Evaluating distant metastases in breast cancer: from biology to outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Prognostic factors in 1,038 women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27518

7 January 2021

Identifiers

DOI

10.1002/CNCR.27518

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22415862%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference